MatthewStuartMcKinneyMD

Oncology • Durham, NC

Cancer Genetics/Cancer Risk Assessment, Cutaneous Lymphoma, HIV/AIDS Related, Hematologic Oncology

Assistant Professor of Medicine at Duke University Medical Center, Department of Medicine, Division of Hematologic Malignancies

Join to view full profile

Dr. McKinney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McKinney's full profile

Already have an account?

Office
20 Duke Medicine Circle
Durham, NC 27710
Phone+1 919-684-8964

Fax+1 919-684-5325

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
Duke University HospitalResidency, Internal Medicine, 2006 - 2009
Duke University School of MedicineClass of 2006

Certifications & Licensure

NC State Medical License 2006 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Expansion of an Academic Molecular Tumor Board to Enhance Access to Biomarker-Driven Trials and Therapies in the Rural Southeastern United States.
Anivarya Kumar, Jennifer R Owen, Nicholette T Sloat, Elizabeth Maynard, Vanessa M Hill
Current Oncology. 2024-11-16
Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical Practice.
Chenyu Lin, Katherine I Zhou, Michelle F Green, Bennett A Caughey, John H Strickler
Hematology Reports. 2024-09-30
1 citations
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from t...
William G Wierda, Nirav N Shah, Chan Y Cheah, David Lewis, Marc S Hoffmann
The Lancet. Haematology. 2024-09-01

Abstracts/Posters

A Phase 1 Study of ACTR087 in Combination with Rituximab, in Subjects with Relapsed or Refractory CD20-Positive B-Cell Lymphoma
Matthew S. McKinney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma
Matthew S. McKinney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Novel Mechanisms for Resistance to Targeted Therapy Identified through Machine Learning Approaches in 1167 RNA-Seq Drug Exposure Profiles in Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Hepatosplenic T-cell Lymphoma: Recent Progress and Future ConsiderationsSeptember 16th, 2020